# Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

> **NCT04469699** · PHASE2 · TERMINATED · sponsor: **University Hospital Muenster** · enrollment: 30 (actual)

## Conditions studied

- Glioblastoma Multiforme, Adult

## Interventions

- **DRUG:** Stereotactic biopsy followed by stereotactical photodynamic therapy with 5-aminolevulinic acid
- **PROCEDURE:** Stereotactic biopsy

## Key facts

- **NCT ID:** NCT04469699
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-12
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469699, "Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04469699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*